Building Complexity and Achieving Selectivity through Catalysis – Case Studies from the Pharmaceutical Pipeline

Matthew G. Beaver; Seb Caille; Robert P. Farrell; Andreas R. Rötheli; Austin G. Smith; Jason S. Tedrow; Oliver R. Thiel

doi:10.1055/s-0040-1706869

Synlett, Inhaltsverzeichnis

Synlett 2021; 32(05): 457-471
DOI: 10.1055/s-0040-1706869

account

The Power of Transition Metals: An Unending Well-Spring of New Reactivity

Building Complexity and Achieving Selectivity through Catalysis – Case Studies from the Pharmaceutical Pipeline

Matthew G. Beaver

^aAmgen Inc., Process Development, Drug Substance Technologies, 360 Binney Street, Cambridge, Massachusetts, United States

,

Seb Caille

^bAmgen Inc., Process Development, Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California 91320, United States eMail: jtedrow@amgen.com eMail: othiel@amgen.com

,

Robert P. Farrell

^bAmgen Inc., Process Development, Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California 91320, United States eMail: jtedrow@amgen.com eMail: othiel@amgen.com

,

Andreas R. Rötheli

^aAmgen Inc., Process Development, Drug Substance Technologies, 360 Binney Street, Cambridge, Massachusetts, United States

,

Austin G. Smith

^bAmgen Inc., Process Development, Drug Substance Technologies, One Amgen Center Drive, Thousand Oaks, California 91320, United States eMail: jtedrow@amgen.com eMail: othiel@amgen.com

,

Jason S. Tedrow∗

^aAmgen Inc., Process Development, Drug Substance Technologies, 360 Binney Street, Cambridge, Massachusetts, United States

,

Oliver R. Thiel∗

^aAmgen Inc., Process Development, Drug Substance Technologies, 360 Binney Street, Cambridge, Massachusetts, United States

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Dedicated to Prof. Barry M. Trost in recognition of his contributions to the advancement of transition-metal catalysis and his efforts in training the next generations of organic chemists.

Abstract

The last decade of small-molecule process development has witnessed a trend of increasing molecular complexity for clinical candidates. The continued advance of novel catalytic methods and subsequent translation to efficient and scalable processes has enabled process chemists to overcome the challenges associated with increasing complexity. This Account highlights several examples from the process chemistry laboratories at Amgen.

1 Introduction

2 The Evolution of Molecular Complexity

3 Catalysis as a Lever to Build Complexity

4 Ru(II)-Catalyzed Dynamic Kinetic Resolution Enabling the Manufacture of AMG 232

5 Application of Enzymatic Desymmetrization toward Scale-Up of the MCL-1 Inhibitor AMG 176

6 Synthesis of Fucostatin 1: Catalytic Asymmetric Transfer Hydrogenation

7 Manganese-Catalyzed Asymmetric Epoxidation To Prepare a Carfilzomib Intermediate

8 Asymmetric Reduction Strategies: Novel Apelin Receptor Agonists and AMG 986

9 Conclusions

Key words

catalysis - process development - drug development - green chemistry - synthetic methods

Volltext

Referenzen

References

1a Trost BM. Science 1991; 254: 1471
1b Trost BM. Angew. Chem. Int. Ed. 1995; 34: 259 ; Angew. Chem. 1995, 107, 285

2 Tucker JL, Faul MM. Nature 2016; 534: 27
3 Roshangar FD, Colberg J, Dunn PJ, Gallou F, Hayler JD, Koenig SG, Kopach ME, Leahy DK, Mergelsberg I, Tucker JL, Sheldon RA, Senanayake CH. Green Chem. 2017; 19: 281
4 Caille S, Cui S, Faul MM, Mennen SM, Tedrow JS, Walker SD. J. Org. Chem. 2019; 84: 4583
5 Faul MM, Busacca CA, Eriksson MC, Hicks F, Kiesman WF, Smulkowski M, Orr JD, Pfeiffer S. Org. Process Res. Dev. 2014; 18: 594

6a Walters WP, Green J, Weiss JR, Murcko MA. J. Med. Chem. 2011; 54: 6405
6b Dandapani S, Marcaurelle LA. Nat. Chem. Biol. 2010; 6: 861
6c Mendez-Lucio JL, Medina-Franco JL. Drug Discovery Today 2017; 22: 120

7a Gluck WL, Gounder MM, Frank R, Eskens F, Blay JY, Cassier PA, Soria J.-C, Chawla S, de Weger V, Wagner AJ, Siegal D, De Vos F, Rasmussen E, Henary HA. Invest. New Drugs 2020; 38: 831
7b Sun D, Li Z, Rew Y, Gribble M, Bartberger MD, Beck HP, Canon J, Chen A, Chen X, Chow D, Deignan J, Duquette J, Eksterowicz J, Fisher B, Fox BM, Fu J, Gonzalez AZ, Gonzalez-Lopez De Turiso F, Houze JB, Huang X, Jiang M, Jin L, Kayser F, Liu JJ, Lo M.-C, Long AM, Lucas B, McGee LR, McIntosh J, Mihalic J, Oliner JD, Osgood T, Peterson ML, Roveto P, Saiki AY, Shaffer P, Toteva M, Wang Y, Wang YC, Wortman S, Yakowec P, Yan X, Ye Q, Yu D, Yu M, Zhao X, Zhou J, Zhu J, Olson SH, Medina JC. J. Med. Chem. 2014; 57: 1454

8 For a literature example of high trans alkylation of cis-5,6-disubstituted δ-lactones, see: Grieco PA, Williams E, Tanaka H, Gilman S. J. Org. Chem. 1980; 45: 3537

9a Cochran BM, Corbett MT, Correll TL, Fang Y.-Q, Flick TG, Jones SC, Silva Elipe MV, Smith AG, Tucker JL, Vounatsos F, Wells G, Yeung D, Walker SD, Bio MM, Caille S. J. Org. Chem. 2019; 84: 4763
9b Lucas BS, Fisher B, McGee LR, Olson SH, Medina JC, Cheung E. J. Am. Chem. Soc. 2012; 134: 12855

10 Smith AG, Bio MM, Colyer JT, Diker K, Gorins G, Jones SC, Silva Elipe M, Tedrow JS, Walker SD, Caille S. Org. Proc. Res. Dev. 2020; 24: 1164
11 Matsumura K, Arai N, Hori K, Saito T, Sayo N, Ohkuma T. J. Am. Chem. Soc. 2011; 133: 10696
12 For examples of ester reductions using Noyori-type Ru catalysts and H₂, see: Werkmeister S, Junge K, Beller M. Org. Process Res. Dev. 2014; 18: 289 ; and references cited therein
13 Rescourio G, Gonzalez AZ, Jabri S, Belmontes B, Moody G, Whittington D, Huang X, Caenepeel S, Cardozo M, Cheng AC, Chow D, Dou H, Jones A, Kelly RC, Li Y, Lizarzaburu M, Lo MC, Mallari R, Meleza C, Rew Y, Simonovich S, Sun D, Turcotte S, Ya X, Wong SG, Yanez E, Zancanella M, Houze J, Medina JG, Hughes PE, Brown SP. J. Med. Chem. 2019; 62: 10258
14 Cyclobutane anhydride manufactured via photochemical [2+2] cycloaddition of ethylene and maleic anhydride was limited to ~500 g annually at $36,000/kg.
15 Daly AM, Gilheany DG. Tetrahedron: Asymmetry 2003; 14: 127
16 Laumen K, Schneider M. Tetrahedron Lett. 1985; 26: 2073
17 Ulrich A, Breitgoff D, Klein P, Laumen KE, Schneider ME. Tetrahedron Lett. 1989; 30: 1793
18 Katritzky AR, Rachwal S, Rachwal B. J. Chem. Soc., Perkin Trans. 1 1986; 791
19 Chartrain M, Chu L. Curr. Pharm. Biotechnol. 2008; 9: 447
20 Becker DJ, Lowe JB. Glycobiology 2003; 13: 41R
21 Allen JG, Mujacic M, Frohn MJ, Pickrell AJ, Kodama P, Bagal D, San Miguel T, Sickmier EA, Osgood S, Swietlow A, Li V, Jordan JB, Kim K.-W, Russo A.-M, Kim Y.-J, Caille S, Achmatowicz M, Thiel O, Fotsch CH, Reddy P, McCarter JD. ACS Chem. Biol. 2016; 11: 2734
22 Achmatowicz MA, Allen JG, Bio MM, Bartberger MD, Borths CJ, Colyer JT, Crockett RD, Hwang T.-L, Koek JN, Osgood SA, Roberts SW, Swietlow A, Thiel OR, Caille S. J. Org. Chem. 2016; 81: 4736
23 d-(–)-Arabinose can be purchased for less than $100 kg.
24 Wu J, Serianni AS. Carbohydr. Res. 1991; 210: 51
25 Pyranoside products form and crystallize from the reaction mixture upon prolonged (>10 h) exposure to acid.
26 Heyns K, Heinemann R. Ann. 1947; 558: 147
27 The pH was controlled using additions of NaHCO₃.

28a Guthrie JP. Can. J. Chem. 1975; 53: 898
28b Stewart R, Van Dyke JD. Can. J. Chem. 1972; 50: 1992

29 Hashiguchi S, Fujii A, Takehara J, Ikariya T, Noyori R. J. Am. Chem. Soc. 1995; 117: 7562
30 The dr was 65:35 with S,S-TsDPEN RuCl (mes).
31 Zhao Y, Truhlar DG. Theor. Chem. Acc. 2008; 120: 215
32 The predominance of species B was corroborated by CCSD(T)/aug-cc-pVDZ single-point energies upon the M06-2X/6-31+G(d,p) geometries.
33 Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Francis B, Reu FJ, Somlo G, Zonder J, Song K, Stewart AK, Stadtmauer E, Kunkel L, Wear S, Wong AF, Orlowski RZ, Jagannath S. Blood 2012; 120: 2817

34a Dornan PK, Anthoine T, Beaver MG, Cheng GC, Cohen DE, Cui S, Lake WE, Langille NF, Lucas SP, Patel J, Powazinik WIV, Roberts SW, Scardino C, Tucker JL, Spada S, Zeng A, Walker SD. Org. Process Res. Dev. 2020; 24: 481
34b Beaver MG, Shi X, Riedel J, Patel P, Zeng A, Corbett MT, Robinson JA, Parsons AT, Cui S, Baucom K, Lovette MA, Icten E, Brown DA, Allian A, Flick TG, Chen W, Yang N, Walker SD. Org. Process Res. Dev. 2020; 24: 490

35 Cussó O, Ribas X, Costas M. Chem. Commun. 2015; 51: 14285
36 Wang B, Miao C, Wang S, Xia C, Sun W. Chem. Eur. J. 2012; 18: 6750

37a Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Siswanto BB, Sliwa K, Filippatos G. ESC Heart Fail. 2014; 1: 4
37b Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG. Circ. Heart Fail. 2013; 6: 606
37c Mozzafarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J.-P, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER. III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB. Circulation 2016; 133: 447
37d Gomez-Soto FM, Andrey JL, Garcia-Egido AA, Escobar MA, Romero SP, Garcia-Arjona R. Int. J. Cardiol. 2011; 151: 40
37e Tanai E, Frantz S. Compr. Physiol. 2015; 6: 187

38a Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG. F, Coats AJ. S, Falk V, Ramón González-Juanatey J, Harjola V.-K, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM. C, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. Eur. J. Heart Fail. 2016; 18: 891
38b Gomberg-Maitland M, Baran DA, Fuster V. Arch. Intern. Med. 2001; 161: 342

39 Ason B, Chen Y, Guo Q, Hoagland KM, Chui RW, Fielden M, Sutherland W, Chen R, Zhang Y, Mihardja S, Ma X, Li X, Sun Y, Liu D, Nguyen K, Wang J, Li N, Rajamani S, Qu Y, Gao BX, Boden A, Chintalgattu V, Turk JR, Chan J, Hu LA, Dransfield P, Houze J, Wong J, Ma J, Pattaropong V, Véniant MM, Vargas HM, Swaminath G, Khakoo AY. JCI Insight 2020; 5: e132898
40 Chen N, Chen X, Chen Y, Cheng AC, Connors RV, Deignan J, Dransfield PJ, Du X, Fu Z, Heath JA, Horne DB, Houze J, Kaller MR, Khakoo AY, Kopecky DJ, Lai S.-J, Ma LR, McGee JC, Medina JT, Mihalic N, Nishimura SH, Olson V, Pattaropong G, Swaminath Z, Wang X, Yang K, Yeh W.-C, DeBenedetto MV, Farrell RP, Hedley SJ, Judd TC, Kayser F. WO2016187308A1, 2016
41 Kraft S, Ryan K, Kargbo RB. J. Am. Chem. Soc. 2017; 139: 11630
42 Paul J, Palmer C. WO1999015481A1, 1999
43 Yuasa Y, Yuasa Y, Tsuruta H. Can. J. Chem. 1998; 76: 1304
44 unpublished results.
45 The desired enantiomer could be upgraded to >99% ee following a single recrystallization of the isolated product.
46 Both enantiomers of Josiphos J216 are known and are available on kilogram scale. For a literature reference, see: Blaser H.-U, Breiden W, Pugin B, Spindler F, Studer M, Togni A. Top. Catal. 2002; 19: 3
47 Noyori R, Ikeda T, Ohkuma T, Widhalm M, Kitamura M, Takaya H, Akutagawa S, Sayo N, Saito T, Taketomi T, Kumobayashi H. J. Am. Chem. Soc. 1989; 111: 9134

For syn selectivity, see:

48a Eustache F, Dalko PI, Cossy J. Org. Lett. 2002; 4: 1263
48b Son S.-M, Lee H.-K. J. Org. Chem. 2014; 79: 2666
48c Limanto J, Krska SW, Dorner BT, Vazquez E, Yoshikawa N, Tan L. Org. Lett. 2010; 12: 512
48d Xiong Z, Pei C, Lv H, Zhang X. Chem. Commun. 2018; 54: 3883

For anti selectivity, see:

48e Seashore-Ludlow B, Villo P, Häcker C, Somfai P. Org. Lett. 2010; 12: 5274
48f Koike T, Murata K, Ikariya T. Org. Lett. 2000; 2: 3833

For a review, see:

48g Bhat V, Welin ER, Guo X, Stoltz BM. Chem. Rev. 2017; 117: 4528
48h Wang D, Astruc D. Chem. Rev. 2015; 115: 6621

49a Hannedouche J, Clarkson GJ, Wills M. J. Am. Chem. Soc. 2004; 126: 986
49b Cheung FK, Hayes AM, Hannedouche J, Yim AS. Y, Wills M. J. Org. Chem. 2005; 70: 3188
49c Nedden HG, Zanotti-Gerosa A, Wills M. Chem. Rec. 2016; 16: 2623

50 Hodgkinson R, Jurčik V, Zanotti-Gerosa A, Nedden HG, Blackaby A, Clarkson GJ, Wills M. Organometallics 2014; 33: 5517

51a Applegate GA, Berkowitz DB. Adv. Synth. Catal. 2015; 357: 1619
51b Kaluzna A, Matsuda T, Sewell AK, Stewart JD. J. Am. Chem. Soc. 2004; 126: 12827
51c Kalaitzakis D, Rozzell JD, Kambourakis S, Smonou I. Org. Lett. 2005; 7: 4799
51d Ravía SP, Carrera I, Seoane GA, Vero S, Gamenara D. Tetrahedron: Asymmetry 2009; 20: 1393
51e Cuetos A, Rioz-Martínez A, Bisogno FR, Grischek B, Lavandera I, de Gonzalo G, Kroutil W, Gotor V. Adv. Synth. Catal. 2012; 354: 1743
51f Deasy RE, Maguire AR. Eur. J. Org. Chem. 2014; 3737
51g Fujisawa T, Yamanaka K, Mobele BI, Shimizu M. Tetrahedron Lett. 1991; 32: 399
51h Maguire AR, O’Riordan N. Tetrahedron Lett. 1999; 40: 9285